Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury.
Vaccines in Multiple Sclerosis.
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.
Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited.
Exercising Impacts on Fatigue, Depression, and Paresthesia in Female Patients with MS.
Autoimmune neuropathies: insights from animal models.
Fumaric Acid Esters Stimulate Astrocytic VEGF Expression through HIF-1α and Nrf2.
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
The potential of LINGO-1 as a therapeutic target for essential tremor.
Multiscale entropy identifies differences in complexity in postural control in women with multiple sclerosis.
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis?
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.
Analysis of humoral immune responses to LM1 ganglioside in guinea pigs.
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues.
Progressive cerebral atrophy in neuromyelitis optica.
Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells.
Misfiring in multiple sclerosis: Cerebellar Channelopathy, a Potential Novel Target?
A Novel Asp121Asn Mutation of Myelin Protein Zero Is Associated with Late-Onset Axonal Charcot-Marie-Tooth Disease, Hearing Loss and Pupil Abnormalities.
The Advances in Neurobiology.
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence.
5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly¬(ADP Ribose)¬Polymerases (PARPs).
Acute disseminated encephalomyelitis: case report and brief review.
Pages
« first
‹ previous
…
708
709
710
711
712
713
714
715
716
…
next ›
last »